Hematological parameters in preterm infants from birth to 16 weeks of age with reference to iron balance

Enni Mäkelä1, Timo I Takala, Pauli Suominen

  • 1Department of Pediatrics, Turku University Hospital, Turku, Finland.

Insights

Serum soluble transferrin receptor (S-TfR) and reticulocyte indices help assess iron balance in preterm neonates. Combining these with hematocrit (Hct) may guide red blood cell (RBC) transfusion decisions.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Intensive Care

Background:

  • Preterm neonates exhibit unique iron metabolism and erythropoiesis.
  • Assessing iron status and need for red blood cell (RBC) transfusions in neonates is clinically significant.

Purpose of the Study:

  • To describe the natural kinetics of serum soluble transferrin receptor (S-TfR), ferritin, and reticulocyte indices in preterm neonates.
  • To determine if these analytes correlate with hematocrit (Hct) levels in guiding RBC transfusion decisions.

Main Methods:

  • Serial analysis of iron deficiency markers and hematological indices in 100 preterm neonates (gestational age ≤34 weeks or birth weight <2000 g) over 16 weeks.
  • Recruitment occurred in a tertiary neonatal intensive care unit.

Main Results:

  • Reticulocyte counts and hemoglobin content (CHr) were highest at birth, decreasing thereafter, and differed significantly based on Hct levels.
  • Serum soluble transferrin receptor (S-TfR) and ferritin levels did not show significant differences based on Hct.
  • RBC transfusions did not significantly impact CHr or reticulocyte count.

Conclusions:

  • Serum soluble transferrin receptor (S-TfR) reflects both erythropoiesis activity and iron balance in preterm infants.
  • Combining reticulocyte indices (CHr, immature reticulocyte fraction) with Hct can provide valuable information for transfusion decisions.
  • These markers may aid in optimizing RBC transfusion strategies in preterm neonates.
Abstract